UNSPSC 51287001: Acedapsone

This classification denotes a sulfone anti-infective agent with the molecular formula C16H16N2O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0GZ72U84TN, chemically known as 4,4-sulphonyldianiline but more generally known as acedapsone, which bears US NIH Compound Identifier 2955. European Medicines Agency schedules Acedapsone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05201MIG.

The term ACEDAPSONE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 24, No. 11 1970, List 10). ACEDAPSONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: S(=O)(=O)(C1CCC(N)CC1)C1CCC(N)CC1.

UNSPSC 51287001 Acedapsone, a Commodity code, shows minimal recent state and local procurement activity aligned with its nominal pharmaceutical scope. The two recent opportunities tagged under this code involve different drug products entirely — one a piggyback pharmaceutical warehouse award for Doxycycline Hyclate and Ciprofloxacin Hydrochloride, the other a procurement for Naloxone and drug deactivation systems — indicating the code does not reflect active purchasing of acedapsone itself at the state and local level. When state and local bodies do source pharmaceuticals through this code's nominal family, they use cooperative purchasing vehicles such as MMCAP Infuse consortiums and route acquisitions through piggyback awards to qualified distributors rather than direct-buy solicitations. Issuing bodies have included the Illinois Department of Public Health and Seminole County, Florida, suggesting activity spans state health departments and county public-health offices, though the sample is too small to establish a pattern.

The two records show geographic activity in Illinois and Florida, with response dates in 2026 and 2023 respectively. The Illinois Department of Public Health completed an award through MMCAP Infuse to Chartwell Rx LLC on August 28, 2026 for $2.99 million over three years (Bid 26-482DPH-PREPD-B-53392, Invitation for Bid). Seminole County issued an IFB (60459723LAS) posted June 30, 2026 seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly delivery to the county's Community Health Building in Sanford, Florida, and a July 26, 2023 response deadline. Neither opportunity directly addresses acedapsone procurement, suggesting the code assignment reflects categorization inconsistency rather than active market demand for this specific pharmaceutical.